Yoshito Takahashi, MD, PhD

Articles by Yoshito Takahashi, MD, PhD

Endocrine Plus Uracil/Tegafur Therapy for Prostate Cancer

ByYoshinari Ono, MD, PhD,Ohinichi Ohshima, MD, PhD,Yoshito Takahashi, MD, PhD,Manabu Kuriyama, MD, PhD,Yukimichi Kawada, MD, PhD

July 1st 1999

A prospective, randomized clinical trial was conducted to evaluate the efficacy of endocrine chemotherapy with uracil and tegafur (in a molar ratio of 4:1 [UFT]) in patients with prostate cancer. The study included two

Latest Updated Articles

Endocrine Plus Uracil/Tegafur Therapy for Prostate Cancer
July 1st 1999

Trending on CancerNetwork

MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer

Novel HP1K Inhibitor Shows Favorable Responses in ccRCC, Solid Tumors

FDA Grants RMAT Designation to RZ-001 in Advanced Hepatocellular Carcinoma

119 Progression-Free Survival (PFS) and Overall Survival (OS) Results From the Phase 3 MONALEESA-3 Trial of Postmenopausal Patients With Hormone Receptor–Positive (HR+)/Human Epidermal Growth Factor Receptor 2–Negative (HER2−) Advanced Breast Cancer (ABC) Treated With Ribociclib (RIB) + Fulvestrant (FUL): A Subgroup Analysis of Patients With Invasive Lobular Carcinoma (ILC)